
Yuichiro Ogura
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 126 publications
ICON-PM: International consensus on nomenclature for adult pathologic myopia.
Journal: Progress in retinal and eye research
Published: May 08, 2026
IMPACT OF FARICIMAB VERSUS AFLIBERCEPT ON EPIRETINAL MEMBRANE FORMATION OVER 2 YEARS IN PATIENTS WITH DIABETIC MACULAR EDEMA IN THE PHASE 3 YOSEMITE AND RHINE TRIALS.
Journal: Retina (Philadelphia, Pa.)
Published: July 16, 2025
Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS).
Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Published: December 27, 2024
To Treat or Not to Treat? Resolving the Question of Subretinal and Intraretinal Fluid in Age-Related Macular Degeneration: A Narrative Review.
Journal: Ophthalmology and therapy
Published: July 17, 2024
Patterns of anti-vascular endothelial growth factor treatment for chorioretinal vascular diseases: Analysis of a nationwide claims database in Japan.
Journal: Annals of clinical epidemiology
Published: September 19, 2023
Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy.
Journal: Journal of clinical medicine
Published: June 17, 2023
Efficacy, Durability, and Safety of Faricimab in Patients From Asian Countries With Diabetic Macular Edema: 1-Year Subgroup Analysis of the Phase III YOSEMITE and RHINE Trials.
Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Published: March 31, 2023
Polypoidal Choroidal Vasculopathy: Updates on Risk Factors, Diagnosis, and Treatments.
Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Published: February 02, 2023
Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration.
Journal: Advances in therapy
Published: December 12, 2021
Last Updated: 09/26/2026